Essays on the Role of Government Regulation and Policy in Health Care Markets

Total Page:16

File Type:pdf, Size:1020Kb

Essays on the Role of Government Regulation and Policy in Health Care Markets University of Kentucky UKnowledge Theses and Dissertations--Economics Economics 2018 ESSAYS ON THE ROLE OF GOVERNMENT REGULATION AND POLICY IN HEALTH CARE MARKETS Grayson L. Forlines University of Kentucky, [email protected] Digital Object Identifier: https://doi.org/10.13023/etd.2018.238 Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Forlines, Grayson L., "ESSAYS ON THE ROLE OF GOVERNMENT REGULATION AND POLICY IN HEALTH CARE MARKETS" (2018). Theses and Dissertations--Economics. 35. https://uknowledge.uky.edu/economics_etds/35 This Doctoral Dissertation is brought to you for free and open access by the Economics at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Economics by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known. I agree that the document mentioned above may be made available immediately for worldwide access unless an embargo applies. I retain all other ownership rights to the copyright of my work. I also retain the right to use in future works (such as articles or books) all or part of my work. I understand that I am free to register the copyright to my work. REVIEW, APPROVAL AND ACCEPTANCE The document mentioned above has been reviewed and accepted by the student’s advisor, on behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of the program; we verify that this is the final, approved version of the student’s thesis including all changes required by the advisory committee. The undersigned agree to abide by the statements above. Grayson L. Forlines, Student Dr. Frank Scott, Major Professor Dr. Jenny Minier, Director of Graduate Studies ESSAYS ON THE ROLE OF GOVERNMENT REGULATION AND POLICY IN HEALTH CARE MARKETS DISSERTATION A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the College of Business and Economics at the University of Kentucky By Grayson L. Forlines Lexington, Kentucky Director: Dr. Frank Scott, Professor of Economics Lexington, Kentucky Copyright© Grayson L. Forlines 2018 ABSTRACT OF DISSERTATION ESSAYS ON THE ROLE OF GOVERNMENT REGULATION AND POLICY IN HEALTH CARE MARKETS Understanding how health care markets function is important not only because com- petition has a direct influence on the price and utilization of health care services, but also because the proper functioning, or lack thereof, of health care markets has a very real impact on patients who depend on health care markets and providers for their personal well-being. In this dissertation, I examine the role of government policies and regulation in health care markets, with a focus on the response of health care providers. In Chapter 1, I analyze the impact of Medicare payment rules on hospital ownership of physician practices. Since the mid-2000’s, there has been a rapid increase in hospital ownership of physician practices, however, there is little empirical research which addresses the causes of this re- cent wave of integration. Medicare’s “provider-based” billing policy allows hospital-owned physician practices to charge higher reimbursement rates for services provided compared to a freestanding, independent physician practice, without altering how or where services are provided. This “site-based” differential creates a premium for physicians to integrate with hospitals, and the size of this differential varies with the types of health care services provided. I find that Medicare payment rules have contributed to hospital ownership of physician practices and that the response varies across physician specialties. A 10 percent increase in the relative reimbursement rate paid to integrated physicians leads to a 1.9 percentage point increase in the probability of hospital ownership for Medical Care special- ties, including cardiology, neurology, and dermatology, which explains about one-third of observed integration of these specialties from 2005 through 2015. Magnitudes for Surgical Care specialties are similar, but more sensitive across specifications. There is no significant response for Primary Care physicians. In combination with other empirical literature which finds that integration between physicians and hospitals typically results in higher prices with no impact on costs or quality of care, I cautiously interpret this responsiveness as ev- idence that Medicare’s provider-based billing policy overcompensates integrated physician practices and leads to an inefficiently high level of vertical integration between physician and hospitals. In Chapter 2, I analyze the effect of anti-fraud enforcement activity on Medicaid spend- ing, with a particular focus on the False Claims Act. The False Claims Act (FCA) is a federal statute which protects the government from making undeserved payments to contractors and suppliers. Individual states have chosen to enact their own versions of the federal FCA, and these statutes have increasingly been used to target health care fraud. FCA statutes commonly include substantial monetary penalties such as “per-violation” monetary fines and tripled damages, as well as a “whistleblower” provision which allows private plaintiffs to initiate a lawsuit and collect a portion of recoveries as a reward. Using variation in state- level FCA legislation, I find state FCAs reduce Medicaid prescription drug spending by 21 percent, while other spending categories - which are less lucrative for FCA lawsuits - are un- responsive. Within the prescription drug category, drugs prone to off-label use show larger declines in response to the whistleblower laws, consistent with FCA lawsuits being used to prosecute pharmaceutical manufacturers for off-label marketing and promotion. Spending and prescription volume for drugs prone to off-label use fall by up to 14 percent. This effect could be driven by pharmaceutical manufacturers’ changes in physician detailing for drugs prone to off-label use and/or physicians’ changes in prescribing behavior. KEYWORDS: Medicare; Vertical Integration; Hospital ownership of physician practices; Medicaid; False Claims Act; Anti-fraud enforcement Author’s signature: Grayson L. Forlines Date: June 26, 2018 ESSAYS ON THE ROLE OF GOVERNMENT REGULATION AND POLICY IN HEALTH CARE MARKETS By Grayson L. Forlines Director of Dissertation: Dr. Frank Scott Director of Graduate Studies: Dr. Jenny Minier Date: June 26, 2018 For Ashley and Maxwell ACKNOWLEDGMENTS I am grateful for the guidance, comments, and help provided by my Dissertation Chair, Dr. Frank Scott, in the writing of this dissertation. I thank the members of my disserta- tion committee, Drs. John Garen, Scott Hankins, and Aaron Yelowitz for their comments, contributions, and feedback. This work has also benefited greatly from the collegiality and attention of faculty members and other graduate students in the Department of Economics at the University of Kentucky. I thank the Schnatter Institute for the Study of Free Enter- prise for the fellowship support during the writing of this dissertation, and I am thankful for the generous donation by Mr. John Schnatter which made this possible. A number of people have contributed to my success in the Ph.D program through their support and encouragement. I am especially grateful for the mentoring offered by Michael Brookshire including the opportunity to work at Brookshire, Barrett & Associates. I thank my parents for their support throughout my undergraduate and graduate student career. Finally, I thank my wife, Ashley, for her love, support, and encouragement as I pursued my Ph.D in economics. iii TABLE OF CONTENTS Acknowledgments . iii Table of Contents . iv List of Tables . vi List of Figures . vii Chapter 1 Drivers of Physician-Hospital Integration: The Role of Medicare Reim- bursement . 1 1.1 Introduction . 1 1.2 Background and Literature . 4 1.2.1 Integration in the 1990s . 4 1.2.2 Integration Today . 4 1.2.3 Consequences and Causes of Physician-Hospital Integration . 6 1.3 Medicare Reimbursement . 12 1.3.1 Medicare Payment Systems . 14 1.3.2 Federal Anti-fraud and Abuse Regulations . 15 1.4 Data . 16 1.4.1 Medicare Physician Fee Schedule and Hospital Outpatient Prospec- tive Payment System . 16 1.4.2 Medicare Utilization and Payment Data . 17 1.4.3 National Ambulatory Medical Care Survey . 20 1.5 Model and Methodology . 23 1.6 Empirical Results . 25 1.7 Robustness . 28 1.7.1 Parallel Trends . 28 1.7.2 Medicare Patient Share . 29 1.7.3 Dynamic Effects . 31 1.8 Discussion . 33 1.8.1 Geographic Variation in Hospital Ownership . 33 1.9 Conclusion . 35 Chapter 2 Outsourcing Fraud Enforcement – Whistleblower Laws and Medicaid Expenditure . 63 2.1 Introduction . 63 2.2 Literature . 66 2.2.1 Fraud Committed Against the Government . 66 2.2.2 The Social Optimality of Whistleblower Laws . 67 2.2.3 Empirical Studies on Health Care Fraud in Public Programs . 67 2.3 The False Claims Act . 68 2.3.1 FCA Utilization and Recoveries . 69 2.3.2 Recent Amendments . 69 iv 2.3.3 FCA Characteristics, Filing Procedure, and the Role of the Whistle- blower . 70 2.4 Conceptual Issues: Why Prescription Drugs? . 71 2.4.1 FCAs and Different Types of Fraud . 71 2.4.2 Policy Confounders .
Recommended publications
  • Zerohack Zer0pwn Youranonnews Yevgeniy Anikin Yes Men
    Zerohack Zer0Pwn YourAnonNews Yevgeniy Anikin Yes Men YamaTough Xtreme x-Leader xenu xen0nymous www.oem.com.mx www.nytimes.com/pages/world/asia/index.html www.informador.com.mx www.futuregov.asia www.cronica.com.mx www.asiapacificsecuritymagazine.com Worm Wolfy Withdrawal* WillyFoReal Wikileaks IRC 88.80.16.13/9999 IRC Channel WikiLeaks WiiSpellWhy whitekidney Wells Fargo weed WallRoad w0rmware Vulnerability Vladislav Khorokhorin Visa Inc. Virus Virgin Islands "Viewpointe Archive Services, LLC" Versability Verizon Venezuela Vegas Vatican City USB US Trust US Bankcorp Uruguay Uran0n unusedcrayon United Kingdom UnicormCr3w unfittoprint unelected.org UndisclosedAnon Ukraine UGNazi ua_musti_1905 U.S. Bankcorp TYLER Turkey trosec113 Trojan Horse Trojan Trivette TriCk Tribalzer0 Transnistria transaction Traitor traffic court Tradecraft Trade Secrets "Total System Services, Inc." Topiary Top Secret Tom Stracener TibitXimer Thumb Drive Thomson Reuters TheWikiBoat thepeoplescause the_infecti0n The Unknowns The UnderTaker The Syrian electronic army The Jokerhack Thailand ThaCosmo th3j35t3r testeux1 TEST Telecomix TehWongZ Teddy Bigglesworth TeaMp0isoN TeamHav0k Team Ghost Shell Team Digi7al tdl4 taxes TARP tango down Tampa Tammy Shapiro Taiwan Tabu T0x1c t0wN T.A.R.P. Syrian Electronic Army syndiv Symantec Corporation Switzerland Swingers Club SWIFT Sweden Swan SwaggSec Swagg Security "SunGard Data Systems, Inc." Stuxnet Stringer Streamroller Stole* Sterlok SteelAnne st0rm SQLi Spyware Spying Spydevilz Spy Camera Sposed Spook Spoofing Splendide
    [Show full text]
  • Healthcare Fraud & Abuse Review 2017
    HEALTHCARE FRAUD & ABUSE REVIEW 2017 i | BASS, BERRY & SIMS HEALTHCARE FRAUD & ABUSE REVIEW 2017 1. A LOOK BACK…A LOOK AHEAD 4. NOTEWORTHY SETTLEMENTS 7. ISSUES TO WATCH 12. FALSE CLAIMS ACT UPDATE 37. STARK LAW/ANTI-KICKBACK STATUTE 40. PHARMACEUTICAL AND MEDICAL DEVICE DEVELOPMENTS 42. APPENDIX – 2017 NOTABLE SETTLEMENTS Hospitals and Health Systems Managed Care/Insurance Hospice Laboratory, Pathology, Radiology and Diagnostics Home Health Specialty Care and Other Provider Entities SNFs and Nursing Homes Individual Providers Pharmaceutical and Device Miscellaneous/Non-Providers Pharmacy Services 70. ABOUT BASS, BERRY & SIMS General (HHS-OIG), along with federal and state law enforcement entities, including 30 Medicaid Fraud Control Units, charged more than 400 defendants, including 115 healthcare professionals, A LOOK BACK… in 41 federal districts for allegedly participating in fraudulent healthcare arrangements resulting in over $1.3 billion in false claims.6 A LOOK AHEAD Occurring in the context of combatting the opioid crisis, the takedown focused on individuals allegedly involved in fraudulent billing of Medicare, Medicaid and TRICARE for medically While the uncertainty associated with legislative efforts to repeal unnecessary prescription and compounded drugs that were not actually purchased or distributed to patients covered by a federal healthcare program. In total, more than 120 the Patient Protection and Affordable Care Act (PPACA) dominated defendants, including physicians, were charged in connection with prescribing and distributing most of the headlines for the healthcare industry last year, it was opioids and narcotics. Nearly 300 individuals—including physicians, nurses and pharmacists— mostly business as usual for the government’s healthcare fraud received exclusion notices from HHS-OIG barring future participation in federal healthcare 7 enforcement efforts.
    [Show full text]
  • Educational Outreach Workbook Notes ______Iowa Fraud Fighters – Shield Your Savings
    IOWA FRAUD FIGHTERS EDUCATIONAL OUTREACH WORKBOOK NOTES ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ ______________________________________________ IOWA FRAUD FIGHTERS – SHIELD YOUR SAVINGS Welcome to the Iowa Insurance Division’s Iowa Fraud Fighters
    [Show full text]
  • 30-3-509-Caffrey-Pdfa.Pdf (1.335Mb)
    Can a Computer Read a Doctor's Mind? Whether Using Data Mining as Proof in Healthcare Fraud Cases is Consistent with the Law of Evidence COLIN CAFFREY* I. IN TRODUCTION .................................................................................509 H. AN EXPLANATION OF DATA MINING ................................................510 III. THE USE OF INFORMATION OBTAINED BY DATA MINING AS E V IDEN CE ..........................................................................................5 11 A. QUESTION ONE: WHETHER THE USE OF PRIOR ACTS BY PRACTITIONERS IS PROPER UNDER THE LAW OF EVIDENCE? .....511 1. Under the FederalRules of Evidence ...............................512 2. Under the Common Law ...................................................513 3. C onclusion ........................................................................516 B. QUESTION TWO: IS TESTIMONY BASED ON DATA MINING PROPER EXPERT TESTIM ONY? .................................................................516 1. Under the FederalRules ...................................................516 2. Under the Common Law ...................................................520 3. C onclusion ........................................................................523 C. QUESTION THREE: DOES THE METHODOLOGY OF DATA MINING SATISFY THE DAUBERTOR FRYE STANDARD? .............................524 1. The D aubert Standard....................................................... 524 2. The Frye Standard............................................................ 528 3. C onclusion
    [Show full text]
  • The Purpose of the False Claims Act of 1863
    MEDICAL MALPRACTICE AS A BASIS FOR A FALSE CLAIMS ACTION? P ATRICK A. SCHEIDERER* INTRODUCTION The purpose of the False Claims Act of 1863 (the “FCA”) is to reimburse the federal government (the “Government”) for funds that are fraudulently taken from it, and to deter such fraud in the future. Congress recognized, in enacting the FCA, that if persons or entities who defraud the Government were forced to repay any funds obtained fraudulently, then individuals who might otherwise attempt such actions would be deterred. Congress, therefore, envisioned that knowing fraud would be avoided. As health care becomes an ever more important debate in American society and the amount of Government funding of health care programs escalates, it is apparent that the increased likelihood of fraud by health care providers is an important problem. Under the FCA, such fraud will be deterred and the Government will be repaid for money fraudulently taken. However, the quality of health care provided to American citizens is also an important concern. In this regard, the question arises whether the FCA can or should be used to help ensure that individuals who are provided government-funded health care receive quality health care. In particular, can or should the FCA be used as an additional punishment of doctors who commit medical malpractice above and beyond the penalties currently available in a civil malpractice action? The answers are unclear. I. BACKGROUND: THE FALSE CLAIMS ACT The FCA was enacted “during the Civil War . to combat fraud and price- gouging in war procurement contracts.”1 It “originated with President Lincoln .
    [Show full text]
  • Healthcare Fraud & Abuse Review 2018
    HEALTHCARE FRAUD & ABUSE REVIEW 2018 1. A LOOK BACK…A LOOK AHEAD 3. NOTEWORTHY SETTLEMENTS 6. ISSUES TO WATCH 12. FALSE CLAIMS ACT UPDATE 37. STARK LAW/ANTI-KICKBACK STATUTE 41. PHARMACEUTICAL AND MEDICAL DEVICE DEVELOPMENTS 44. APPENDIX — 2018 NOTABLE SETTLEMENTS Hospitals and Health Systems Managed Care/Insurance Hospice Laboratory, Pathology, Radiology and Diagnostics Home Health Behavioral Health and Substance Abuse Treatment Services SNFs and Nursing Homes Specialty Care and Other Provider Entities Pharmaceutical and Device Medical Transportation Pharmacy Services Individual Providers 74. ABOUT BASS, BERRY & SIMS an analysis of opioid prescribing data in the Medicare Part D program and identified several A LOOK BACK…. Recoveries attributable to concerning trends, including: (1) that nearly one in three Medicare beneficiaries received an opioid A LOOK AHEAD the healthcare industry were prescription in 2017; (2) identification of Medicare beneficiaries who appeared to be “doctor $2.5 billion in FY 2018 — up shopping;” and (3) identification of almost 300 Perhaps the single most appropriate word to describe the current state from $2.1 billion in FY 2017. prescribers who engaged in questionable opioid of the civil and criminal healthcare fraud enforcement environment prescribing practices by ordering opioids for the 3 is uncertainty. From changes in personnel and policy at the highest highest number of Medicare beneficiaries at serious risk of opioid abuse. And, in July 2018, HHS-OIG issued a release highlighting key vulnerabilities in the Medicare hospice program levels of government to a myriad of state and federal legislative and making numerous recommendations for protecting hospice beneficiaries. In a notable developments, healthcare providers face an unsettled landscape as admission, HHS-OIG acknowledged that the hospice payment system creates incentives for they move into the coming year.
    [Show full text]
  • 118877Ncjrs.Pdf
    If you have issues viewing or accessing this file contact us at NCJRS.gov. " I ! PUBLIC HEARING REPORT and RECOMMENDATIONS by the' STATE OF NEW JERSEY, COMMISSION OF INVESTIGATION ,. on the UBVERSION BY ORGANIZEDCR~tME /~1 ri -q ,1'1-Y', and .' '" ITHER UNSCRUPULOUS ELEMENTS of the tX\'" CHECK CASHING INDUSTRY if ~ ," , '~ 118877 U.S. Department of Justice National Institute of Justice This document has been reproduced exactly as received from the person or organization originating it. Points of view or opinions stated in this document are those of the authors and do not necessarily represent the official position or policies of the National Institute of Justice. Permission to reproduce this copyrighted material has been granted by New Jersey Commission of Investigation to the National Criminal Justice Reference Service (NCJRS). Further reproduction outside of the NCJRS system requires permis' sion of the copyright owner. ACQUISITIONS, '.' .. ~ .. ;f, 1: ...~. PUBLIC HEARING REPORT and RECOMMENDATIONS by the STATE OF NEW JERSEY COMMISSION OF INVESTIGATION on the SUBVERSION BY ORGANIZED CRIME and OTHER UNSCRUPULOUS ELEMENTS of the CHECK CASHING INDUSTRY STATE OF NEW JERSEY COMMISSION OF INVESTIGATION COMMISSIONERS Henry S. Patterson, II, Chairman James R. Zazzali Barry H. Evenchick W. Hunt Dumont EXECUTIVE DIRECTOR James J. Morley Deputy Director Robert J. Clark Assistant Director Helen K. Gardiner Executive Assistant John O. Davies· Counsel to the Commission Charlotte K. Gaal Carol L. Hoekje William DiBuono Ileana N. Saros 28 West State Street eN 045 Trenton, New Jersey 08625 609·292·6767 *Mr. Davies retired effective July 1, 1988, and was succeeded by Thomas W. Cannon.
    [Show full text]
  • Healthcare Fraud & Abuse Review 2020
    2020 A LOOK BACK … A LOOK AHEAD 1 CARES ACT/COVID-19 RELIEF 3 NOTEWORTHY SETTLEMENTS 5 ISSUES TO WATCH 9 FALSE CLAIMS ACT UPDATE 15 STARK LAW/ANTI-KICKBACK STATUTE 34 MANAGED CARE/MEDICARE ADVANTAGE 38 PHARMACEUTICAL AND MEDICAL DEVICE DEVELOPMENTS 40 APPENDIX — 2020 NOTABLE SETTLEMENTS 43 Hospitals and Health Systems Behavioral Health and Substance Abuse Treatment Hospice and Home Health Specialty Care and Other Provider Entities Skilled Nursing Facilities and Nursing Homes Individual Providers Pharmaceutical and Device Other Laboratory, Pathology, Radiology, and Diagnostics ABOUT BASS, BERRY & SIMS 68 turned-offices, and we argued and won key FCA cases on behalf of clients, appearing Civil fraud recoveries by remotely before appellate courts via video DOJ dipped to $2.2 billion conference. in the fiscal year ending For its part and not surprisingly, the September 30, 2020 federal government continued forward with its pursuit of healthcare fraud (FY 2020) as compared to and abuse issues. The Department of $3.1 billion in FY 2019, Justice’s (DOJ) announced results reflect that the government’s healthcare fraud and recoveries attributable enforcement efforts have continued to the healthcare industry unabated. Civil fraud recoveries by DOJ dipped to $2.2 billion in the fiscal year were $1.8 billion in ending September 30, 2020 (FY 2020) as FY 2020, compared with compared to $3.1 billion in FY 2019, and recoveries attributable to the healthcare $2.6 billion in FY 2019. industry were $1.8 billion in FY 2020, compared with $2.6 billion in FY 2019.1 Whistleblowers filed 672 new qui tam A LOOK BACK … lawsuits under the FCA in FY 2020, which represented an increase compared with the prior year, and brought the total number of FCA qui tam lawsuits filed since 2010 to more than A LOOK AHEAD 7,000.
    [Show full text]
  • False Claims Act Amendments Hearings Committee on The
    FALSE CLAIMS ACT AMENDMENTS HEARINGS BEFORE THE SUBCOMMITTEE ONADMINISTRATIVE LAWAND GOVERNMENTAL RELATIONS OF THE COMMITTEE ON THE JUDICIARY HOUSE OF REPRESENTATIVES NINETY-NINTH CONGRESS SECOND SESSION ON FALSE CLAIMS ACT AMENDMENTS FEBRUARY 5 AND 6, 1986 Serial No. 48 Printed for the use of the Committee on the Judiciary U.S. GOVERNMENT PRINTING OFFICE 59-415 O WASHINGTON : 1986 For sale by the Superintendent of Documents, Congressional Sales Office U.S. Government Printing Office, Washington. DC 20402 COMMITTEE ON THE JUDICIARY PETER W. RODINO, JR., New Jersey, Chairman JACK BROOKS, Texas HAMILTON FISH, JR., New York ROBERT W. KASTENMEIER, Wisconsin CARLOS J. MOORHEAD, California DON EDWARDS, California HENRY J. HYDE, Illinois JOHN CONYERS, JR., Michigan THOMAS N. KINDNESS, Ohio JOHN F. SEIBERLING, Ohio DAN LUNGREN, California ROMANO L. MAZZOLI, Kentucky F. JAMES SENSENBRENNER, JR., WILLIAM J. HUGHES, New Jersey Wisconsin MIKE SYNAR, Oklahoma BILL McCOLLUM, Florida PATRICIA SCHROEDER, Colorado E. CLAY SHAW, JR., Florida DAN GLICKMAN, Kansas GEORGE W. GEKAS, Pennsylvania BARNEY FRANK, Massachusetts MICHAEL DEWINE, Ohio GEO. W. CROCKETT, JR., Michigan WILLIAM E. DANNEMEYER, California CHARLES E. SCHUMER, New York HANK BROWN, Colorado BRUCE A. MORRISON, Connecticut PATRICK L. SWINDALL, Georgia EDWARD F. FEIGHAN, Ohio HOWARD COBLE, North Carolina LAWRENCE J. SMITH, Florida HOWARD L. BERMAN, California RICK BOUCHER, Virginia HARLEY O. STAGGERS, JR., West Virginia JOHN BRYANT, Texas M. ELAINE MIELKE, GeneralCounsel GARNER J. CLINE, Staff Director ALAN F. COFFEY, Jr., Associate Counsel SUBCOMMITTEE ON ADMINISTRATIVE LAW AND GOVERNMENTAL RELATIONS DAN GLICKMAN, Kansas, Chairman BARNEY FRANK, Massachusetts THOMAS N. KINDNESS, Ohio GEO. W. CROCKETT, JR., Michigan HANK BROWN, Colorado HOWARD L.
    [Show full text]
  • Hawaii's Fraud Prevention & Resource Guide
    Hawaii’s Hawaii’s FRAUD PREVENTION & RESOURCE GUIDE GUIDE 2ND EDITION & RESOURCE PREVENTION FRAUD 2ND EDITION MAHALO This guide is brought to you by: Department of Commerce and Consumer Affairs Offi ce of the Securities Commissioner Department of Health Executive Offi ce on Aging, Senior Medicare Patrol (SMP Hawaii) Program Department of the Attorney General Crime Prevention and Justice Assistance Division Hawaii’s Fraud Prevention & Resource Guide 2nd Edition LETTER FROM GOVERNOR DAVID IGE Aloha! I am proud to introduce the second edition of Hawaii’s Fraud Prevention & Resource Guide. My administration is deeply committed to protecting our families, caring for our kupuna and providing for our keiki. As part of this ongoing effort, the Department of Commerce and Consumer Affairs, the Department of Health and the Department of the Attorney General have collaborated to produce this helpful guide, one of the most popular state anti-fraud resources. Along with information on how to protect yourself against fraud and who to call to receive help, this guide describes some of the most common types of fraud in Hawaii to help consumers recognize and avoid them. A big mahalo to the state agencies that worked together to develop this important resource for Hawaii consumers. Mahalo nui loa, David Ige Governor of the State of Hawaii Hawaii’s Fraud Prevention & Resource Guide, 2nd Edition This guide is provided by the Department of Commerce and Consumer Affairs, Office of the Securities Commissioner; Department of Health, Executive Office on Aging, Senior Medicare Patrol (SMP Hawaii) and the Department of the Attorney General, Crime Prevention and Justice Assistance Division.
    [Show full text]
  • Teacher Guide 9.1 Fraud and Identity Theft Page 1
    TEACHER GUIDE 9.1 FRAUD AND IDENTITY THEFT PAGE 1 Standard 9: The student will identify and explain consumer fraud and identity theft. Beware! Consumer Fraud Priority Academic Student Skills Personal Financial Literacy Objective 9.1: Describe unfair, deceptive, or fraudulent business Alfredo’s mom is at the practices (e.g., pyramid schemes, bait and switch, and phishing). door to meet him when Objective 9.2: Describe ways to recognize and avoid identity theft he comes from school. (e.g., review monthly financial statements and annual credit reports; His credit card bill and protect personal information and online passwords). came in today’s mail, Objective 9.3: Describe methods to correct problems arising from and Mom is furious. identity theft and fraudulent business practices (e.g., contact national credit bureaus and local/state law enforcement agencies). When she opened the bill, she found charges for magazines on Alfredo’s credit card. She cannot understand why he would order magazines on that card when he promised to use it only for gasoline for his car and school- related expenses. What should Mom do about these magazine charges? Should she take away his credit card because he broke Lesson Objectives his promise? Should she make him pay for those magazines? Identify different kinds of consumer fraud. Should she cancel this Recognize how to prevent being victimized by consumer credit card because it fraud. seems obvious that Determine what steps to take if victimized by consumer Alfredo is not trust- fraud. worthy? © 2008. Oklahoma State Department of Education. All rights reserved. Teacher Guide 9.1 2 Personal Financial Literacy Vocabulary Federal Trade Commission: A federal agency that enforces consumer protection.
    [Show full text]
  • The False Claims Act – 2017 Mid-Year Update Financial Services Sector August 23, 2017 Today’S Panelists
    The False Claims Act – 2017 Mid-Year Update Financial Services Sector August 23, 2017 Today’s Panelists F. Joseph Warin is a partner in the Washington, D.C. office, Chair of the office’s Litigation Department, and Co-Chair of the firm's White Collar Defense and Investigations practice group. His practice focuses on complex civil litigation, white collar crime, and regulatory and securities enforcement – including FCA cases, FCPA investigations, special committee representations, compliance counseling and class action civil litigation. Stuart Delery is a partner in the Washington, D.C. office. He represents corporations and individuals in high-stakes litigation and investigations that involve the federal government across the spectrum of regulatory litigation and enforcement. Previously, as the Acting Associate Attorney General of the United States (the third-ranking position at the Department of Justice) and as Assistant Attorney General for the Civil Division, he supervised the DOJ's enforcement efforts under the FCA and FIRREA. Mylan Denersteinis a partner in the New York office. She is Co-Chair of the firm's Public Policy practice group, and a member of the White Collar Defense and Investigations, Securities Litigation, Appellate, and Crisis Management practice groups. She handles a broad range of complex litigation, as well as white collar, legislative and investigation matters. She is former Counsel to New York State Governor Andrew Cuomo, and previously served as Deputy Chief of the Criminal Division of the U.S. Attorney's Office in the Southern District of New York. James Zelenay is a partner in the Los Angeles office and a member of the firm's Litigation Department.
    [Show full text]